Concepedia

Douglas L. Orsi

DL

Statistics

Publications

9

Citations

439

H-Index

9

Active since

2014

Affiliations

University of Kansas(Current)

Dana-Farber Cancer Institute

Harvard University

Broad Institute

Bayer (Germany)

Douglas L. Orsi is an author at University of Kansas specializing in chemistry, drug discovery, and catalysis.

ORCID

Publications per year

2014–2022

9

Publications

9

Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition

Siddharth S. Matikonda, Douglas L. Orsi, Verena Staudacher et al. · Chemical Science · 2014 · 153 citations · Full text

, , +13

Exploiting the unusual effects of fluorine in methodology

Douglas L. Orsi, Ryan A. Altman · Chemical Communications · 2017 · 84 citations

, , +12

Ligand‐Controlled Regiodivergent Palladium‐Catalyzed Decarboxylative Allylation Reaction to Access α,α‐Difluoroketones

Ming‐Hsiu Yang, Douglas L. Orsi, Ryan A. Altman · Angewandte Chemie International Edition · 2015 · 83 citations

, , +11

Ligand‐Controlled Regiodivergent Palladium‐Catalyzed Decarboxylative Allylation Reaction to Access α,α‐Difluoroketones

Ming‐Hsiu Yang, Douglas L. Orsi, Ryan A. Altman · Angewandte Chemie · 2015 · 24 citations

, , +11

Development of <b>VU6019650</b>: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M<sub>5</sub> Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder

Aaron T. Garrison, Douglas L. Orsi, Rory A. Capstick et al. · Journal of Medicinal Chemistry · 2022 · 21 citations · Full text

, , +17

1–5 of 9